Like it or not, we are firmly living through "The Austerity Era". We have been here since May 2022.
If you’re in the orthopedic startup space, you’re feeling it. Startups or unprofitable ortho companies must find ways to survive in this "risk-off" market cycle.
Gone are the days of easy venture funding. With inflation and interest rates high, investors are wary, waiting for things to stabilize before pouring capital back into ortho startups. For founders, this means tough decisions are on the table. Right now, it's all about survival—extending runway, driving organic sales, and making it to the other side of this storm when investors are expected to turn "risk-on" again in 2025.
The Reality Check: No More "Growth at All Costs"
Just a year or two ago, investors were chasing orthopedic innovators, eager to fuel rapid growth. But today, they’re more cautious, taking longer to make decisions and requiring stronger proof points before committing capital. If you’ve got a runway problem, it’s time to focus on sustainability over hypergrowth.
Breaking even through organic sales is now a must-have, not a nice-to-have. Here’s how to make it happen:
Focus on Core Markets: Resist the urge to...
